MEDIBANK PRIVATE LIMITED — Director's Dealing 2017

Dec 26, 2017

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity: MEDIBANK PRIVATE LIMITED

ABN: 47 080 890 259

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Craig Drummond
Date of last notice	6 March 2017

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of ‘‘notifiable interest of a director’’ should be disclosed in this part.

disclosed in this part.
Direct or indirect interest	Direct
Nature of indirect interest(including registered holder)Note: Provide details of the circumstances giving rise to the relevantinterest.	Performance Rights pursuant to the MedibankPrivate Limited Performance Rights Plan(‘Performance Rights Plan’)
Date of change	27 December 2017
No. of securities held prior to change	765,306 Performance Rights
Class	Performance Rights
Number acquired	1,031,254 Performance Rights including:•200,570 Performance Rights being theFY17 Deferred Short Term Incentive; and•830,684 Performance Rights being theFY18 Long Term Incentive.
Number disposed	Nil
Value/ConsiderationNote: If consideration is non-cash, provide details and estimatedvaluation	PerformanceRightsgrantedatnilconsiderationunderthetermsofthePerformance Rights Plan
No. of securities held after change	1,796,560 Performance Rights
Nature of changeExample: on-market trade, off-market trade, exercise of options, issueof securities under dividend reinvestment plan, participation in buy-back	Grant of Performance Rights under thePerformance Rights Plan, being the FY17Deferred Short term Incentive and FY18 LongTerm Incentive

• See chapter 19 for defined terms.

01/01/2011

Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Direct or indirect interest	Indirect
Nature of indirect interest(including registered holder)Note: Provide details of the circumstances giving rise to the relevantinterest.	Beneficial interest in Medibank PrivateLimited Ordinary Shares_(‘Ordinary Shares’)_held via INVIA Custodian Pty Limited onbehalf of B& CDrummond
Date of change	N/A
No. of securities held prior to change	50,000 Ordinary Shares
Class	Ordinary Shares
Number acquired	N/A
Number disposed	N/A
Value/ConsiderationNote: If consideration is non-cash, provide details and estimatedvaluation	N/A
No. of securities held after change	50,000 Ordinary Shares
Nature of changeExample: on-market trade, off-market trade, exercise of options, issueof securities under dividend reinvestment plan, participation in buy-back	N/A

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of ‘‘notifiable interest of a director’’ should be disclosed in this part.

Detail of contract	N/A
Nature of interest	N/A
Name of registered holder(if issued securities)	N/A
Date of change	N/A
No. and class of securities to whichinterest related prior to changeNote: Details are only required for a contract inrelation to which the interest has changed	N/A
Interest acquired	N/A
Interest disposed	N/A
Value/ConsiderationNote: If consideration is non-cash, provide details andan estimated valuation	N/A
Interest after change	N/A

• See chapter 19 for defined terms.

01/01/2011

Appendix 3Y Page 2

Appendix 3Y Change of Director’s Interest Notice

Part 3 –[+] Closed period

Part 3 –+Closed period
Were the interests in the securities or contracts detailedabove traded during a+closed period where prior written**clearance was required? **	No
If so, was prior written clearance provided to allow the tradeto proceed during this period?	N/A
If prior written clearance was provided, on what date was thisprovided?	N/A

• See chapter 19 for defined terms.

01/01/2011

Appendix 3Y Page 3